REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,536,000 | -1.4% | 233,841 | 0.0% | 0.51% | +18.7% |
| Q4 2020 | $6,627,000 | +12.7% | 233,841 | 0.0% | 0.43% | -16.1% |
| Q3 2020 | $5,879,000 | -45.8% | 233,841 | -47.3% | 0.52% | -50.4% |
| Q2 2020 | $10,839,000 | +56.0% | 443,841 | -5.4% | 1.04% | +54.2% |
| Q1 2020 | $6,946,000 | -9.4% | 469,332 | -0.7% | 0.68% | +5.8% |
| Q4 2019 | $7,669,000 | +24.8% | 472,532 | 0.0% | 0.64% | -6.3% |
| Q3 2019 | $6,143,000 | +0.2% | 472,532 | 0.0% | 0.68% | +68.1% |
| Q2 2019 | $6,129,000 | -17.7% | 472,532 | 0.0% | 0.40% | -14.4% |
| Q1 2019 | $7,447,000 | -21.7% | 472,532 | 0.0% | 0.47% | -16.7% |
| Q4 2018 | $9,512,000 | -19.0% | 472,532 | 0.0% | 0.57% | +0.9% |
| Q3 2018 | $11,742,000 | -9.5% | 472,532 | 0.0% | 0.56% | -15.0% |
| Q2 2018 | $12,971,000 | +31.9% | 472,532 | +48.0% | 0.66% | +6.9% |
| Q1 2018 | $9,835,000 | – | 319,313 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |